Click for best price

PD1 PDL1 Inhibitors Market Size, Share 2024

Report Overview

PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.

The global PD-1 and PDL-1 Inhibitors market size was estimated at USD 39550 million in 2023 and is projected to reach USD 72711.06 million by 2032, exhibiting a CAGR of 7.00% during the forecast period.

North America PD-1 and PDL-1 Inhibitors market size was estimated at USD 11579.37 million in 2023, at a CAGR of 6.00% during the forecast period of 2025 through 2032.

This report provides a deep insight into the global PD-1 and PDL-1 Inhibitors market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD-1 and PDL-1 Inhibitors Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD-1 and PDL-1 Inhibitors market in any manner.

Global PD-1 and PDL-1 Inhibitors Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

GlaxoSmithKline plc

Bristol-Myers Squibb Company

Arcus Biosciences

Inc.

Agenus Inc

F. Hoffmann-La Roche Ltd

Astra Zeneca PLC

Beigene Ltd

Incyte Corporation

Biocad

CStone Pharmaceuticals

Ono Pharmaceutical

Merck

Shanghai Junshi Bioscience Co. Ltd

Shanghai Henlius Biotech

Inc.

Jiangsu HengRui Medicine Co.

Ltd.

Market Segmentation (by Type)

Pembrolizumab

Nivolumab

Atezolizumab

Durvalumab

Avelumab

Market Segmentation (by Application)

Stomach Cancer

Liver Cancer

Kidney Ccancer

Bladder Cancer

Cervical Cancer

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the PD-1 and PDL-1 Inhibitors Market

Overview of the regional outlook of the PD-1 and PDL-1 Inhibitors Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter

Report Attributes	Report Details
Report Title	Global PD-1 and PDL-1 Inhibitors Market Research Report 2025, Forecast to 2032
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2023
Forecast Year	2031
Number of Pages	151 Pages
Customization Available	Yes, the report can be customized as per your need.

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of PD-1 and PDL-1 Inhibitors
1.2 Key Market Segments
1.2.1 PD-1 and PDL-1 Inhibitors Segment by Type
1.2.2 PD-1 and PDL-1 Inhibitors Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD-1 and PDL-1 Inhibitors Market Overview
2.1 Global Market Overview
2.1.1 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global PD-1 and PDL-1 Inhibitors Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD-1 and PDL-1 Inhibitors Market Competitive Landscape
3.1 Global PD-1 and PDL-1 Inhibitors Sales by Manufacturers (2019-2025)
3.2 Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Manufacturers (2019-2025)
3.3 PD-1 and PDL-1 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD-1 and PDL-1 Inhibitors Average Price by Manufacturers (2019-2025)
3.5 Manufacturers PD-1 and PDL-1 Inhibitors Sales Sites, Area Served, Product Type
3.6 PD-1 and PDL-1 Inhibitors Market Competitive Situation and Trends
3.6.1 PD-1 and PDL-1 Inhibitors Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD-1 and PDL-1 Inhibitors Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD-1 and PDL-1 Inhibitors Industry Chain Analysis
4.1 PD-1 and PDL-1 Inhibitors Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of PD-1 and PDL-1 Inhibitors Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD-1 and PDL-1 Inhibitors Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type (2019-2025)
6.3 Global PD-1 and PDL-1 Inhibitors Market Size Market Share by Type (2019-2025)
6.4 Global PD-1 and PDL-1 Inhibitors Price by Type (2019-2025)
7 PD-1 and PDL-1 Inhibitors Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD-1 and PDL-1 Inhibitors Market Sales by Application (2019-2025)
7.3 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) by Application (2019-2025)
7.4 Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2025)
8 PD-1 and PDL-1 Inhibitors Market Consumption by Region
8.1 Global PD-1 and PDL-1 Inhibitors Sales by Region
8.1.1 Global PD-1 and PDL-1 Inhibitors Sales by Region
8.1.2 Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region
8.2 North America
8.2.1 North America PD-1 and PDL-1 Inhibitors Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD-1 and PDL-1 Inhibitors Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD-1 and PDL-1 Inhibitors Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD-1 and PDL-1 Inhibitors Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 PD-1 and PDL-1 Inhibitors Market Production by Region
9.1 Global Production of PD-1 and PDL-1 Inhibitors by Region (2019-2025)
9.2 Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Region (2019-2025)
9.3 Global PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America PD-1 and PDL-1 Inhibitors Production
9.4.1 North America PD-1 and PDL-1 Inhibitors Production Growth Rate (2019-2025)
9.4.2 North America PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe PD-1 and PDL-1 Inhibitors Production
9.5.1 Europe PD-1 and PDL-1 Inhibitors Production Growth Rate (2019-2025)
9.5.2 Europe PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan PD-1 and PDL-1 Inhibitors Production (2019-2025)
9.6.1 Japan PD-1 and PDL-1 Inhibitors Production Growth Rate (2019-2025)
9.6.2 Japan PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China PD-1 and PDL-1 Inhibitors Production (2019-2025)
9.7.1 China PD-1 and PDL-1 Inhibitors Production Growth Rate (2019-2025)
9.7.2 China PD-1 and PDL-1 Inhibitors Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 GlaxoSmithKline plc
10.1.1 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Basic Information
10.1.2 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Overview
10.1.3 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Market Performance
10.1.4 GlaxoSmithKline plc Business Overview
10.1.5 GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors SWOT Analysis
10.1.6 GlaxoSmithKline plc Recent Developments
10.2 Bristol-Myers Squibb Company
10.2.1 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Basic Information
10.2.2 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Overview
10.2.3 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Market Performance
10.2.4 Bristol-Myers Squibb Company Business Overview
10.2.5 Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors SWOT Analysis
10.2.6 Bristol-Myers Squibb Company Recent Developments
10.3 Arcus Biosciences
10.3.1 Arcus Biosciences PD-1 and PDL-1 Inhibitors Basic Information
10.3.2 Arcus Biosciences PD-1 and PDL-1 Inhibitors Product Overview
10.3.3 Arcus Biosciences PD-1 and PDL-1 Inhibitors Product Market Performance
10.3.4 Arcus Biosciences PD-1 and PDL-1 Inhibitors SWOT Analysis
10.3.5 Arcus Biosciences Business Overview
10.3.6 Arcus Biosciences Recent Developments
10.4 Inc.
10.4.1 Inc. PD-1 and PDL-1 Inhibitors Basic Information
10.4.2 Inc. PD-1 and PDL-1 Inhibitors Product Overview
10.4.3 Inc. PD-1 and PDL-1 Inhibitors Product Market Performance
10.4.4 Inc. Business Overview
10.4.5 Inc. Recent Developments
10.5 Agenus Inc
10.5.1 Agenus Inc PD-1 and PDL-1 Inhibitors Basic Information
10.5.2 Agenus Inc PD-1 and PDL-1 Inhibitors Product Overview
10.5.3 Agenus Inc PD-1 and PDL-1 Inhibitors Product Market Performance
10.5.4 Agenus Inc Business Overview
10.5.5 Agenus Inc Recent Developments
10.6 F. Hoffmann-La Roche Ltd
10.6.1 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Basic Information
10.6.2 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Overview
10.6.3 F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
10.6.4 F. Hoffmann-La Roche Ltd Business Overview
10.6.5 F. Hoffmann-La Roche Ltd Recent Developments
10.7 Astra Zeneca PLC
10.7.1 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Basic Information
10.7.2 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Overview
10.7.3 Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Market Performance
10.7.4 Astra Zeneca PLC Business Overview
10.7.5 Astra Zeneca PLC Recent Developments
10.8 Beigene Ltd
10.8.1 Beigene Ltd PD-1 and PDL-1 Inhibitors Basic Information
10.8.2 Beigene Ltd PD-1 and PDL-1 Inhibitors Product Overview
10.8.3 Beigene Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
10.8.4 Beigene Ltd Business Overview
10.8.5 Beigene Ltd Recent Developments
10.9 Incyte Corporation
10.9.1 Incyte Corporation PD-1 and PDL-1 Inhibitors Basic Information
10.9.2 Incyte Corporation PD-1 and PDL-1 Inhibitors Product Overview
10.9.3 Incyte Corporation PD-1 and PDL-1 Inhibitors Product Market Performance
10.9.4 Incyte Corporation Business Overview
10.9.5 Incyte Corporation Recent Developments
10.10 Biocad
10.10.1 Biocad PD-1 and PDL-1 Inhibitors Basic Information
10.10.2 Biocad PD-1 and PDL-1 Inhibitors Product Overview
10.10.3 Biocad PD-1 and PDL-1 Inhibitors Product Market Performance
10.10.4 Biocad Business Overview
10.10.5 Biocad Recent Developments
10.11 CStone Pharmaceuticals
10.11.1 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Basic Information
10.11.2 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Overview
10.11.3 CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Market Performance
10.11.4 CStone Pharmaceuticals Business Overview
10.11.5 CStone Pharmaceuticals Recent Developments
10.12 Ono Pharmaceutical
10.12.1 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Basic Information
10.12.2 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Overview
10.12.3 Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Market Performance
10.12.4 Ono Pharmaceutical Business Overview
10.12.5 Ono Pharmaceutical Recent Developments
10.13 Merck
10.13.1 Merck PD-1 and PDL-1 Inhibitors Basic Information
10.13.2 Merck PD-1 and PDL-1 Inhibitors Product Overview
10.13.3 Merck PD-1 and PDL-1 Inhibitors Product Market Performance
10.13.4 Merck Business Overview
10.13.5 Merck Recent Developments
10.14 Shanghai Junshi Bioscience Co. Ltd
10.14.1 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Basic Information
10.14.2 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Overview
10.14.3 Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Market Performance
10.14.4 Shanghai Junshi Bioscience Co. Ltd Business Overview
10.14.5 Shanghai Junshi Bioscience Co. Ltd Recent Developments
10.15 Shanghai Henlius Biotech
10.15.1 Shanghai Henlius Biotech PD-1 and PDL-1 Inhibitors Basic Information
10.15.2 Shanghai Henlius Biotech PD-1 and PDL-1 Inhibitors Product Overview
10.15.3 Shanghai Henlius Biotech PD-1 and PDL-1 Inhibitors Product Market Performance
10.15.4 Shanghai Henlius Biotech Business Overview
10.15.5 Shanghai Henlius Biotech Recent Developments
10.16 Inc.
10.16.1 Inc. PD-1 and PDL-1 Inhibitors Basic Information
10.16.2 Inc. PD-1 and PDL-1 Inhibitors Product Overview
10.16.3 Inc. PD-1 and PDL-1 Inhibitors Product Market Performance
10.16.4 Inc. Business Overview
10.16.5 Inc. Recent Developments
10.17 Jiangsu HengRui Medicine Co.
10.17.1 Jiangsu HengRui Medicine Co. PD-1 and PDL-1 Inhibitors Basic Information
10.17.2 Jiangsu HengRui Medicine Co. PD-1 and PDL-1 Inhibitors Product Overview
10.17.3 Jiangsu HengRui Medicine Co. PD-1 and PDL-1 Inhibitors Product Market Performance
10.17.4 Jiangsu HengRui Medicine Co. Business Overview
10.17.5 Jiangsu HengRui Medicine Co. Recent Developments
10.18 Ltd.
10.18.1 Ltd. PD-1 and PDL-1 Inhibitors Basic Information
10.18.2 Ltd. PD-1 and PDL-1 Inhibitors Product Overview
10.18.3 Ltd. PD-1 and PDL-1 Inhibitors Product Market Performance
10.18.4 Ltd. Business Overview
10.18.5 Ltd. Recent Developments
11 PD-1 and PDL-1 Inhibitors Market Forecast by Region
11.1 Global PD-1 and PDL-1 Inhibitors Market Size Forecast
11.2 Global PD-1 and PDL-1 Inhibitors Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe PD-1 and PDL-1 Inhibitors Market Size Forecast by Country
11.2.3 Asia Pacific PD-1 and PDL-1 Inhibitors Market Size Forecast by Region
11.2.4 South America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of PD-1 and PDL-1 Inhibitors by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global PD-1 and PDL-1 Inhibitors Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of PD-1 and PDL-1 Inhibitors by Type (2025-2032)
12.1.2 Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of PD-1 and PDL-1 Inhibitors by Type (2025-2032)
12.2 Global PD-1 and PDL-1 Inhibitors Market Forecast by Application (2025-2032)
12.2.1 Global PD-1 and PDL-1 Inhibitors Sales (K MT) Forecast by Application
12.2.2 Global PD-1 and PDL-1 Inhibitors Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. PD-1 and PDL-1 Inhibitors Market Size Comparison by Region (M USD)
Table 5. Global PD-1 and PDL-1 Inhibitors Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Manufacturers (2019-2025)
Table 7. Global PD-1 and PDL-1 Inhibitors Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global PD-1 and PDL-1 Inhibitors Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PDL-1 Inhibitors as of 2022)
Table 10. Global Market PD-1 and PDL-1 Inhibitors Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers PD-1 and PDL-1 Inhibitors Sales Sites and Area Served
Table 12. Manufacturers PD-1 and PDL-1 Inhibitors Product Type
Table 13. Global PD-1 and PDL-1 Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of PD-1 and PDL-1 Inhibitors
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. PD-1 and PDL-1 Inhibitors Market Challenges
Table 22. Global PD-1 and PDL-1 Inhibitors Sales by Type (K MT)
Table 23. Global PD-1 and PDL-1 Inhibitors Market Size by Type (M USD)
Table 24. Global PD-1 and PDL-1 Inhibitors Sales (K MT) by Type (2019-2025)
Table 25. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Type (2019-2025)
Table 26. Global PD-1 and PDL-1 Inhibitors Market Size (M USD) by Type (2019-2025)
Table 27. Global PD-1 and PDL-1 Inhibitors Market Size Share by Type (2019-2025)
Table 28. Global PD-1 and PDL-1 Inhibitors Price (USD/MT) by Type (2019-2025)
Table 29. Global PD-1 and PDL-1 Inhibitors Sales (K MT) by Application
Table 30. Global PD-1 and PDL-1 Inhibitors Market Size by Application
Table 31. Global PD-1 and PDL-1 Inhibitors Sales by Application (2019-2025) & (K MT)
Table 32. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application (2019-2025)
Table 33. Global PD-1 and PDL-1 Inhibitors Sales by Application (2019-2025) & (M USD)
Table 34. Global PD-1 and PDL-1 Inhibitors Market Share by Application (2019-2025)
Table 35. Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2025)
Table 36. Global PD-1 and PDL-1 Inhibitors Sales by Region (2019-2025) & (K MT)
Table 37. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region (2019-2025)
Table 38. North America PD-1 and PDL-1 Inhibitors Sales by Country (2019-2025) & (K MT)
Table 39. Europe PD-1 and PDL-1 Inhibitors Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific PD-1 and PDL-1 Inhibitors Sales by Region (2019-2025) & (K MT)
Table 41. South America PD-1 and PDL-1 Inhibitors Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales by Region (2019-2025) & (K MT)
Table 43. Global PD-1 and PDL-1 Inhibitors Production (K MT) by Region (2019-2025)
Table 44. Global PD-1 and PDL-1 Inhibitors Revenue (US$ Million) by Region (2019-2025)
Table 45. Global PD-1 and PDL-1 Inhibitors Revenue Market Share by Region (2019-2025)
Table 46. Global PD-1 and PDL-1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America PD-1 and PDL-1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe PD-1 and PDL-1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan PD-1 and PDL-1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China PD-1 and PDL-1 Inhibitors Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Basic Information
Table 52. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Product Overview
Table 53. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. GlaxoSmithKline plc Business Overview
Table 55. GlaxoSmithKline plc PD-1 and PDL-1 Inhibitors SWOT Analysis
Table 56. GlaxoSmithKline plc Recent Developments
Table 57. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Basic Information
Table 58. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Product Overview
Table 59. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Bristol-Myers Squibb Company Business Overview
Table 61. Bristol-Myers Squibb Company PD-1 and PDL-1 Inhibitors SWOT Analysis
Table 62. Bristol-Myers Squibb Company Recent Developments
Table 63. Arcus Biosciences PD-1 and PDL-1 Inhibitors Basic Information
Table 64. Arcus Biosciences PD-1 and PDL-1 Inhibitors Product Overview
Table 65. Arcus Biosciences PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Arcus Biosciences PD-1 and PDL-1 Inhibitors SWOT Analysis
Table 67. Arcus Biosciences Business Overview
Table 68. Arcus Biosciences Recent Developments
Table 69. Inc. PD-1 and PDL-1 Inhibitors Basic Information
Table 70. Inc. PD-1 and PDL-1 Inhibitors Product Overview
Table 71. Inc. PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Inc. Business Overview
Table 73. Inc. Recent Developments
Table 74. Agenus Inc PD-1 and PDL-1 Inhibitors Basic Information
Table 75. Agenus Inc PD-1 and PDL-1 Inhibitors Product Overview
Table 76. Agenus Inc PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Agenus Inc Business Overview
Table 78. Agenus Inc Recent Developments
Table 79. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Basic Information
Table 80. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Product Overview
Table 81. F. Hoffmann-La Roche Ltd PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. F. Hoffmann-La Roche Ltd Business Overview
Table 83. F. Hoffmann-La Roche Ltd Recent Developments
Table 84. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Basic Information
Table 85. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Product Overview
Table 86. Astra Zeneca PLC PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Astra Zeneca PLC Business Overview
Table 88. Astra Zeneca PLC Recent Developments
Table 89. Beigene Ltd PD-1 and PDL-1 Inhibitors Basic Information
Table 90. Beigene Ltd PD-1 and PDL-1 Inhibitors Product Overview
Table 91. Beigene Ltd PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Beigene Ltd Business Overview
Table 93. Beigene Ltd Recent Developments
Table 94. Incyte Corporation PD-1 and PDL-1 Inhibitors Basic Information
Table 95. Incyte Corporation PD-1 and PDL-1 Inhibitors Product Overview
Table 96. Incyte Corporation PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Incyte Corporation Business Overview
Table 98. Incyte Corporation Recent Developments
Table 99. Biocad PD-1 and PDL-1 Inhibitors Basic Information
Table 100. Biocad PD-1 and PDL-1 Inhibitors Product Overview
Table 101. Biocad PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Biocad Business Overview
Table 103. Biocad Recent Developments
Table 104. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Basic Information
Table 105. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Product Overview
Table 106. CStone Pharmaceuticals PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. CStone Pharmaceuticals Business Overview
Table 108. CStone Pharmaceuticals Recent Developments
Table 109. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Basic Information
Table 110. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Product Overview
Table 111. Ono Pharmaceutical PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Ono Pharmaceutical Business Overview
Table 113. Ono Pharmaceutical Recent Developments
Table 114. Merck PD-1 and PDL-1 Inhibitors Basic Information
Table 115. Merck PD-1 and PDL-1 Inhibitors Product Overview
Table 116. Merck PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Merck Business Overview
Table 118. Merck Recent Developments
Table 119. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Basic Information
Table 120. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Product Overview
Table 121. Shanghai Junshi Bioscience Co. Ltd PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Shanghai Junshi Bioscience Co. Ltd Business Overview
Table 123. Shanghai Junshi Bioscience Co. Ltd Recent Developments
Table 124. Shanghai Henlius Biotech PD-1 and PDL-1 Inhibitors Basic Information
Table 125. Shanghai Henlius Biotech PD-1 and PDL-1 Inhibitors Product Overview
Table 126. Shanghai Henlius Biotech PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Shanghai Henlius Biotech Business Overview
Table 128. Shanghai Henlius Biotech Recent Developments
Table 129. Inc. PD-1 and PDL-1 Inhibitors Basic Information
Table 130. Inc. PD-1 and PDL-1 Inhibitors Product Overview
Table 131. Inc. PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Inc. Business Overview
Table 133. Inc. Recent Developments
Table 134. Jiangsu HengRui Medicine Co. PD-1 and PDL-1 Inhibitors Basic Information
Table 135. Jiangsu HengRui Medicine Co. PD-1 and PDL-1 Inhibitors Product Overview
Table 136. Jiangsu HengRui Medicine Co. PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Jiangsu HengRui Medicine Co. Business Overview
Table 138. Jiangsu HengRui Medicine Co. Recent Developments
Table 139. Ltd. PD-1 and PDL-1 Inhibitors Basic Information
Table 140. Ltd. PD-1 and PDL-1 Inhibitors Product Overview
Table 141. Ltd. PD-1 and PDL-1 Inhibitors Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. Ltd. Business Overview
Table 143. Ltd. Recent Developments
Table 144. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Region (2025-2032) & (K MT)
Table 145. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Region (2025-2032) & (M USD)
Table 146. North America PD-1 and PDL-1 Inhibitors Sales Forecast by Country (2025-2032) & (K MT)
Table 147. North America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2032) & (M USD)
Table 148. Europe PD-1 and PDL-1 Inhibitors Sales Forecast by Country (2025-2032) & (K MT)
Table 149. Europe PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2032) & (M USD)
Table 150. Asia Pacific PD-1 and PDL-1 Inhibitors Sales Forecast by Region (2025-2032) & (K MT)
Table 151. Asia Pacific PD-1 and PDL-1 Inhibitors Market Size Forecast by Region (2025-2032) & (M USD)
Table 152. South America PD-1 and PDL-1 Inhibitors Sales Forecast by Country (2025-2032) & (K MT)
Table 153. South America PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2032) & (M USD)
Table 154. Middle East and Africa PD-1 and PDL-1 Inhibitors Consumption Forecast by Country (2025-2032) & (Units)
Table 155. Middle East and Africa PD-1 and PDL-1 Inhibitors Market Size Forecast by Country (2025-2032) & (M USD)
Table 156. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Type (2025-2032) & (K MT)
Table 157. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Type (2025-2032) & (M USD)
Table 158. Global PD-1 and PDL-1 Inhibitors Price Forecast by Type (2025-2032) & (USD/MT)
Table 159. Global PD-1 and PDL-1 Inhibitors Sales (K MT) Forecast by Application (2025-2032)
Table 160. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of PD-1 and PDL-1 Inhibitors
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global PD-1 and PDL-1 Inhibitors Market Size (M USD), 2019-2032
Figure 5. Global PD-1 and PDL-1 Inhibitors Market Size (M USD) (2019-2032)
Figure 6. Global PD-1 and PDL-1 Inhibitors Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. PD-1 and PDL-1 Inhibitors Market Size by Country (M USD)
Figure 11. PD-1 and PDL-1 Inhibitors Sales Share by Manufacturers in 2023
Figure 12. Global PD-1 and PDL-1 Inhibitors Revenue Share by Manufacturers in 2023
Figure 13. PD-1 and PDL-1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market PD-1 and PDL-1 Inhibitors Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by PD-1 and PDL-1 Inhibitors Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global PD-1 and PDL-1 Inhibitors Market Share by Type
Figure 18. Sales Market Share of PD-1 and PDL-1 Inhibitors by Type (2019-2025)
Figure 19. Sales Market Share of PD-1 and PDL-1 Inhibitors by Type in 2023
Figure 20. Market Size Share of PD-1 and PDL-1 Inhibitors by Type (2019-2025)
Figure 21. Market Size Market Share of PD-1 and PDL-1 Inhibitors by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global PD-1 and PDL-1 Inhibitors Market Share by Application
Figure 24. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application (2019-2025)
Figure 25. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Application in 2023
Figure 26. Global PD-1 and PDL-1 Inhibitors Market Share by Application (2019-2025)
Figure 27. Global PD-1 and PDL-1 Inhibitors Market Share by Application in 2023
Figure 28. Global PD-1 and PDL-1 Inhibitors Sales Growth Rate by Application (2019-2025)
Figure 29. Global PD-1 and PDL-1 Inhibitors Sales Market Share by Region (2019-2025)
Figure 30. North America PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America PD-1 and PDL-1 Inhibitors Sales Market Share by Country in 2023
Figure 32. U.S. PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada PD-1 and PDL-1 Inhibitors Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico PD-1 and PDL-1 Inhibitors Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe PD-1 and PDL-1 Inhibitors Sales Market Share by Country in 2023
Figure 37. Germany PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific PD-1 and PDL-1 Inhibitors Sales and Growth Rate (K MT)
Figure 43. Asia Pacific PD-1 and PDL-1 Inhibitors Sales Market Share by Region in 2023
Figure 44. China PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America PD-1 and PDL-1 Inhibitors Sales and Growth Rate (K MT)
Figure 50. South America PD-1 and PDL-1 Inhibitors Sales Market Share by Country in 2023
Figure 51. Brazil PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa PD-1 and PDL-1 Inhibitors Sales Market Share by Region in 2023
Figure 56. Saudi Arabia PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa PD-1 and PDL-1 Inhibitors Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global PD-1 and PDL-1 Inhibitors Production Market Share by Region (2019-2025)
Figure 62. North America PD-1 and PDL-1 Inhibitors Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe PD-1 and PDL-1 Inhibitors Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan PD-1 and PDL-1 Inhibitors Production (K MT) Growth Rate (2019-2025)
Figure 65. China PD-1 and PDL-1 Inhibitors Production (K MT) Growth Rate (2019-2025)
Figure 66. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global PD-1 and PDL-1 Inhibitors Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global PD-1 and PDL-1 Inhibitors Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global PD-1 and PDL-1 Inhibitors Market Share Forecast by Type (2025-2032)
Figure 70. Global PD-1 and PDL-1 Inhibitors Sales Forecast by Application (2025-2032)
Figure 71. Global PD-1 and PDL-1 Inhibitors Market Share Forecast by Application (2025-2032)

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $3095

Multi User Price : $4048

Enterprise Price : $4333

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

Global PD-1 and PDL-1 Inhibitors Market Research Report 2025, Forecast to 2032